I agree that this site is using cookies. You can find further informations here.
X
Tsirizani-Galileya, Lufina
23  results:
Search for persons X
?
1

Isoniazid preventive therapy-related adverse events among M..:

Tsirizani-Galileya, Lufina ; Milanzi, Elasma ; Mungwira, Randy...
Medicine.  101 (2022)  39 - p. e30591 , 2022
Link: https://doi.org/10.1097/..
 
?
2

Isoniazid preventive therapy-related adverse events among M..:

Tsirizani-Galileya, Lufina ; Milanzi, Elasma ; Mungwira, Randy...
Medicine.  , 2022
Link: http://hdl.handle.net/10..
 
?
3

Isoniazid preventive therapy-related adverse events among M..:

Tsirizani-Galileya, Lufina ; Milanzi, Elasma ; Mungwira, Randy...
https://archive.lstmed.ac.uk/21320/1/Isoniazid_preventive_therapy_related_adverse.118.pdf.  , 2022
Link: https://archive.lstmed.a..
 
?
4

Evaluating pediatric tuberculosis dosing guidelines: A mode..:

Galileya, Lufina Tsirizani ; Wasmann, Roeland E. ; Chabala, Chishala...
PLOS Medicine.  20 (2023)  11 - p. e1004303 , 2023
Link: https://doi.org/10.1371/..
 
?
5

Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamin..:

Nkosi-Gondwe, Thandile ; Robberstad, Bjarne ; Opoka, Robert...
Trials.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

Revisiting Co-trimoxazole Prophylaxis for African Adults in..:

Laurens, Matthew B ; Mungwira, Randy G ; Nampota, Nginache...
Clinical Infectious Diseases.  73 (2021)  6 - p. 1058-1065 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Simulated rifampicin exposures after adding 75 mg or 150 mg..:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.g002.  , 2023
Link: https://doi.org/10.1371/..
 
?
8

Final model parameters for rifampicin, isoniazid, and pyraz..:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.t003.  , 2023
Link: https://doi.org/10.1371/..
 
?
9

Plot of maturation of clearance and bioavailability:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.g005.  , 2023
Link: https://doi.org/10.1371/..
 
?
10

Evaluating pediatric tuberculosis dosing guidelines: A mode..:

Lufina Tsirizani Galileya ; Roeland E Wasmann ; Chishala Chabala...
https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004303&type=printable.  , 2023
Link: https://doi.org/10.1371/..
 
?
11

Concentration versus time plots for simulated steady-state ..:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.g003.  , 2023
Link: https://doi.org/10.1371/..
 
?
12

Supplementary material:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.s001.  , 2023
Link: https://doi.org/10.1371/..
 
?
13

Characteristics of studies included in the pooled analysis:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.t001.  , 2023
Link: https://doi.org/10.1371/..
 
?
14

Patient characteristics stratified by study:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.t002.  , 2023
Link: https://doi.org/10.1371/..
 
?
15

Simulated tuberculosis drug exposures achieved in children ..:

Lufina Tsirizani Galileya ; Roeland E. Wasmann ; Chishala Chabala...
doi:10.1371/journal.pmed.1004303.g004.  , 2023
Link: https://doi.org/10.1371/..
 
1-15